Saudi Press

Saudi Arabia and the world
Saturday, Jun 21, 2025

Contraceptive ‘mini pills’ to be offered over the counter in UK

Contraceptive ‘mini pills’ to be offered over the counter in UK

Progesterone pills can be dispensed by pharmacists without prescription from late July, for a charge
Women will be able to buy the contraceptive pill over the counter for the first time in 60 years after a landmark ruling from the UK’s drug regulator.

From the end of July two brands of progesterone-only “mini pills” will be available for as little as under £7.50 a month without a prescription and after a brief consultation with a pharmacist, making them much more accessible to a wider range of women and girls.

The pills contain desogestrel, a synthetic progesterone that inhibits ovulation and prevents fertilisation by thickening the cervical mucus and thinning the uterus lining.

The decision was heralded as “good news for women and families” by June Raine, the chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA).

“Pharmacists have the expertise to advise women on whether desogestrel is an appropriate and safe oral contraceptive pill for them to use and to give women the information they need, to make informed choices,” she said.

However, sexual health doctors called on the government to make the pills free in community pharmacies, since they are available free of charge with a doctor’s prescription, and to make a wider range of brands available.

The two pills, Lovima and Hana, are considered safe for most women to take. Combined oestrogen and progesterone pills, which still require a prescription, carry risks to women who are over 35 and smoke that are considered to potentially outweigh the benefits.

According to Maxwellia, which manufactures Lovima, a month’s supply will cost £10. HRA Pharma, which produces Hana, said it would cost £9.95 for one month and £21.95 for three. The contraceptive pill was first introduced on the NHS in 1961 – but was prescribed only to married women for the first six years.

Research by the Guardian based on freedom of information requests showed that almost nine in 10 women who received contraception from the GP or pharmacies in 2017-18 took the pill. The combined pill was marginally more popular, with 1.7 million women opting for that (55%) and 1.4 million choosing the mini pill (45%).

The MHRA’s decision to reclassify the desogestrel products follows a safety review by the Commission on Human Medicines (CHM) and a public consultation taking in views from patients, pharmacists and doctors.

Edward Morris, the president of the Royal College of Obstetricians and Gynaecologists, said he was delighted that some contraceptive pills would be available in local pharmacies after the college’s years of campaigning against “unnecessary barriers” for women and girls.

He said: “Even before the pandemic, too many women and girls were struggling to access basic women’s health services. The consequences of this include an increase in the number of unplanned pregnancies, which can result in poorer outcomes for women and their babies.”

Robbie Turner, the director of pharmacy at the Royal Pharmaceutical Society, said community pharmacies tended to be more conveniently located, and that pharmacists were well equipped to provide women with expert advice on contraception.

Asha Kasliwal, the president of Faculty of Sexual and Reproductive Healthcare, said she fully supported the reclassification of progesterone-only pills as a pharmacy medicine.

She said: “The fragmented sexual and reproductive healthcare system is notoriously difficult for women to navigate, and successive cuts to public health budgets have made it harder for women to get the contraception they need. Reclassification may also reduce unnecessary pressures on GPs, who will not need to see patients for repeat prescriptions.

“However, reclassification of some brands is only the first step, and buying contraception should definitely not be the only solution. We are calling for these pills to be available to everyone for free in community pharmacies, as well as the reclassification of other contraceptives.”
Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
G7 Leaders Fail to Reach Consensus on Key Global Issues
Mass exodus in Tehran as millions try to flee following Trump’s evacuation order
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Netanyahu Signals Potential Regime Change in Iran
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
Iran Conducts Ballistic Missile Launches Amid Heightened Tensions with Israel
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
Shock Within Iran’s Leadership: Khamenei’s Failed Plan to Launch 1,000 Missiles Against Israel
Trump's Anti-War Stance Tested Amid Israel-Iran Conflict
UK Deploys Jets to Middle East Amid Rising Tensions
Exiled Iranian Prince Reza Pahlavi Urges Overthrow of Khamenei Regime
Wreck of $17 Billion San José Galleon Identified Off Colombia After 300 Years
Iran Launches Extensive Missile Attack on Israel Following Israeli Strikes on Nuclear Sites
Israel Issues Ultimatum to Iran Over Potential Retaliation and Nuclear Facilities
Black Box Recovered from Air India Crash Site
Coinbase CEO Warns Bitcoin Could Supplant US Dollar Amid Mounting National Debt
Trump to Iran: Make a Deal — Sign or Die
Operation "Like a Lion": Israel Strikes Iran in Unprecedented Offensive
Israel Launches 'Operation Rising Lion' Targeting Iranian Nuclear and Military Sites
Israeli Forces Intercept Gaza-Bound Aid Vessel Carrying Greta Thunberg
IMF Warns of Severe Global Trade War Impacts on Emerging Markets
Syria to Reconnect to Global Economy After 14 Years of Isolation
Israel Confirms Arming Gaza Clan to Counter Hamas Influence
Global News Roundup: From Ukraine's strategic military strikes and Russia's demands and Tensions Escalate in Ukraine, to serious legal issues faced by Britons in Bali and Trump's media criticism, the latest developments highlight a turbulent landscape
U.S. Reduces Military Presence in Syria
Trump Demands Iran End All Uranium Enrichment in Nuclear Talks
Iran Warns Europe Against Politicizing UN Nuclear Report
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
European and Arab Ministers Convene in Madrid to Address Gaza Conflict
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
×